Peritoneal Mesothelioma and Cisplatin

Peritoneal Mesothelioma and Cisplatin

Peritoneal mesothelioma is a rare and aggressive cancer that affects the lining of the abdomen (peritoneum). Cisplatin is a chemotherapy drug that is sometimes used in the treatment of peritoneal mesothelioma. Here are key aspects:

Chemotherapy for Peritoneal Mesothelioma:

Peritoneal mesothelioma is often challenging to treat due to its aggressive nature and limited treatment options. Chemotherapy is one of the main approaches used to target and kill cancer cells.

Cisplatin as a Chemotherapy Agent:

Cisplatin is a platinum-based chemotherapy drug that works by interfering with the DNA inside cancer cells, preventing them from dividing and growing. It is commonly used in the treatment of various cancers, including mesothelioma.

Combination Therapy:

Cisplatin is frequently used in combination with other chemotherapy drugs to enhance its effectiveness. Combinations may include drugs like pemetrexed or gemcitabine.

Hyperthermic Intraperitoneal Chemotherapy (HIPEC):

In some cases of peritoneal mesothelioma, a treatment called hyperthermic intraperitoneal chemotherapy (HIPEC) may be employed. During surgery, heated chemotherapy is circulated within the abdominal cavity to target any remaining cancer cells.